The cDNA encoding CLU was amplified by reverse transcription polymerase chain reaction (RT-PCR). The cDNA of CLU was cloned into pGC-FU vector. Lentiviral carrying CLU cDNA were generated and harvested as described previously. Briefly, HepG2 cells were infected twice for a total of 2 days (1 day for each infection). Control cell line was generated by infection with viruses containing the empty vector by following the same protocol.
negative control. A double-stranded oligonucleotide specific to exon II of the sCLU mRNA (CCGGGATGAAGACTCTGCTGCTGTTCTCGAGAACAGCAGCAGAGTCT TCATCTTTTTG) was annealed and inserted into the shRNA expression vector pGCSIL-GFP. Because the exon II is unique to sCLU, the shRNAs target exon II is specific to sCLU and have no effects on other forms CLU. Lentiviral carrying CLU shRNA or scrambled shRNA were used to infect target cells (SMMC7721 and HCCLM3). The lentivirus was transfected into SMMC7721 and HCCLM3 cells with a multiplicity of infection (MOI) of 10 to 50 (optimal MOI is 20). All lentiviral vectors expressed GFP, which allowed us to measure their infection efficiency in transfected cells.
The cDNA encoding CLU was amplified by reverse transcription polymerase chain reaction (RT-PCR). The cDNA of CLU was cloned into pGC-FU vector. Lentiviral carrying CLU cDNA were generated and harvested as described previously. Briefly, HepG2 cells were infected twice for a total of 2 days (1 day for each infection). Control cell line was generated by infection with viruses containing the empty vector by following the same protocol.
RNA isolation and real-time RT-PCR
Total RNA was extracted from cells using TRIzol reagent (Invitrogen) and reversely transcribed using the PrimeScript™ RT Reagent Kit (Perfect Real Time) (TaKaRa Biotechnology). The real-time polymerase chain reaction (PCR) was subsequently performed according to the manufacturer's instructions (TaKaRa Biotechnology). The expression levels were normalized against the internal reference gene GAPDH, and the relative expression levels were displayed using the 2 -ΔΔCt method.
Gene knockdown using siRNA
Short interfering RNA specifically against MMP13, Akt and EIF3I genes (Biotend, 
Migration and invasion assays
Cell migration was performed by transwell assay (BD Biosciences, CA, USA).
Briefly, 5 × 10 4 cells in serum-free DMEM were seeded on a membrane (8.0-μm pore size) inserted in a well of a 24-well plate. DMEM containing 10% FBS was added to the lower chamber of each well. After 24 h, cells in the upper chamber were removed by cotton swab and the cells that had reached the underside of the membrane were fixed and stained with crystal violet (1% in methyl alcohol) for 10 min. The cells that located on the underside of the filter (5 fields / filter) were counted. The cell invasion assay was carried out similarly, except that the matrigel (BD Biosciences, CA, USA) was added to each well 6 h before cells were seeded on the membrane. After 48 h, matrigel and any remaining cells in the upper chamber were removed by cotton swabs. Cells on the lower surface of the membrane were fixed and stained as described above.
Immunocytochemistry and confocal microscopy
Cells were grown on glass coverslips. After an attachment period of 24 h, cells were 
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